Feedback / Questions
bamlanivimab/etesevimab (LY-CoV555/LY-CoV016) - Eli Lilly
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/38820002
Dianzhuo Wang; Eugene I Shakhnovich; Marian Huot; Vaibhav Mohanty
May 31, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next